BJU Int
2009, 104:107–114.PubMedCrossRef 22. Chou TC, Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs on selleck screening library Enzyme inhibitors. Adv Enzyme Regul 1984, 22:27–55.PubMedCrossRef 23. Ashkenazi A, Holland P, Eckhardt : Ligand based Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor-Related NU7441 molecular weight Apoptosis-Inducing Ligand (rhApo2L/TRAIL). J Clin Oncol 2008, 26:3621–3630.PubMedCrossRef 24. Hsu H, Shu HB, Pan MG, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
Cell 1996, 84:299–306.PubMedCrossRef 25. Muzio M, Chinnaiyan AM, Kischkel FC, O’Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death–inducing signaling PF-6463922 concentration complex. Cell 1996, 85:817–827.PubMedCrossRef 26. Chopra DP, Menard RE, Januszewski J, Mattingly RR: TNF-α mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett 2004, 203:145–154.PubMedCrossRef 27. Mana SK, Aggarwal BB: All-trans-retinoic acid up regulates TNF receptors and potentiates TNF-induced activation of nuclear factors-кB, activated protein-1 and apoptosis in human lung cancer cells. Oncogene 2000, 19:2110–2119.CrossRef 28. Strasser A, O’Connor L, Dixit VM: Apoptosis signaling. Annu Rev Biochem 2000, 69:217–245.PubMedCrossRef 29. Adams JM, Cory S: SB-3CT Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001, 26:61–66.PubMedCrossRef 30. Lee JH, Takahashi
T, Yasuhara N, Inazawa J, Kamada S, Tsujimoto Y: Bis, a Bcl-2- binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 1999, 18:6183–6190.PubMedCrossRef 31. Aichberger KJ, Mayerhofer M, Gleixner KV, Krauth MT, Gruze A, Pickl WF, Wacheck V, Selzer E, Müllauer L, Agis H, Sillaber C, Valent P: Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412. Blood 2007, 109:3031–3041.PubMed 32. Degli-Esposti MA, Davis-Smith T, Din WS, Smolak PJ, Goodwin RG, Smith CA: Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells. J Immunol 1997, 158:1756–1762.PubMed 33.